South Asian Journal of Cancer

ORIGINAL ARTICLE
Year
: 2018  |  Volume : 7  |  Issue : 2  |  Page : 118--122

Practical consensus recommendations on Her2 +ve breast cancer with solitary brain mets


Nitesh Rohatgi1, A Munshi2, P Bajpai3, M Singh4, S Sahai2, M Ahmad5, K Singh6, H Singh7, Purvish M Parikh8, S Aggarwal9 
1 Department of Medical Oncology, Max Hospital, New Delhi, India
2 Department of Radiation Oncology, Fortis Hospital, Gurugram, Haryana, India
3 Department of Medical Oncology, Manipal Super Specialty Hospital, New Delhi, India
4 Department of Medical Oncology, Mahavir Cancer Sansthan, Patna, Bihar, India
5 Department of Radiation Oncology, Jolly Grant Himalayan Institute, Dehradoon, Uttarakhand, India
6 Department of Radiation Oncology, MAMS, New Delhi, India
7 Department of Radiaton Oncology, Action Balajee Cancer Center, New Delhi, India
8 Department of Oncology, Shalby Cancer and Research Institute, Mumbai, Maharashtra, India
9 Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India

Correspondence Address:
Dr. Nitesh Rohatgi
Department of Medical Oncology, Max Hospital, New Delhi
India

Breast cancer is a common cause of brain metastases, with metastases occurring in at least 10–16% of patients. Longer survival of patients with metastatic breast cancer and the use of better imaging techniques are associated with an increased incidence of brain metastases. Current therapies include surgery, whole-brain radiation therapy, stereotactic radiosurgery, chemotherapy and targeted therapies. However, the timing and appropriate use of these therapies is controversial and careful patient selection by using available prognostic tools is extremely important. Expert oncologist discussed on the mode of treatment to extend the OS and improve the quality of life ofHER2-positivebreast cancer patients with Solitary brain metastases. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at this practical consensus recommendations for the benefit of community oncologists.


How to cite this article:
Rohatgi N, Munshi A, Bajpai P, Singh M, Sahai S, Ahmad M, Singh K, Singh H, Parikh PM, Aggarwal S. Practical consensus recommendations on Her2 +ve breast cancer with solitary brain mets.South Asian J Cancer 2018;7:118-122


How to cite this URL:
Rohatgi N, Munshi A, Bajpai P, Singh M, Sahai S, Ahmad M, Singh K, Singh H, Parikh PM, Aggarwal S. Practical consensus recommendations on Her2 +ve breast cancer with solitary brain mets. South Asian J Cancer [serial online] 2018 [cited 2020 Mar 28 ];7:118-122
Available from: http://journal.sajc.org/article.asp?issn=2278-330X;year=2018;volume=7;issue=2;spage=118;epage=122;aulast=Rohatgi;type=0